- Home
- DERM vs PROF Comparison
DERM vs PROF Comparison
Compare DERM & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- PROF
- Stock Information
- Founded
- DERM 2014
- PROF N/A
- Country
- DERM United States
- PROF Canada
- Employees
- DERM N/A
- PROF N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- PROF Medical/Dental Instruments
- Sector
- DERM Health Care
- PROF Health Care
- Exchange
- DERM Nasdaq
- PROF Nasdaq
- Market Cap
- DERM 181.0M
- PROF 149.7M
- IPO Year
- DERM 2021
- PROF N/A
- Fundamental
- Price
- DERM $8.06
- PROF $5.27
- Analyst Decision
- DERM Strong Buy
- PROF Strong Buy
- Analyst Count
- DERM 2
- PROF 2
- Target Price
- DERM $10.00
- PROF $11.50
- AVG Volume (30 Days)
- DERM 103.3K
- PROF 84.1K
- Earning Date
- DERM 05-14-2025
- PROF 05-08-2025
- Dividend Yield
- DERM N/A
- PROF N/A
- EPS Growth
- DERM N/A
- PROF N/A
- EPS
- DERM N/A
- PROF N/A
- Revenue
- DERM $56,243,000.00
- PROF $11,862,000.00
- Revenue This Year
- DERM $29.83
- PROF $71.17
- Revenue Next Year
- DERM $54.88
- PROF $134.25
- P/E Ratio
- DERM N/A
- PROF N/A
- Revenue Growth
- DERM N/A
- PROF 75.01
- 52 Week Low
- DERM $3.54
- PROF $3.90
- 52 Week High
- DERM $8.24
- PROF $11.42
- Technical
- Relative Strength Index (RSI)
- DERM 65.90
- PROF 56.43
- Support Level
- DERM $6.55
- PROF $5.11
- Resistance Level
- DERM $7.00
- PROF $5.38
- Average True Range (ATR)
- DERM 0.63
- PROF 0.34
- MACD
- DERM 0.13
- PROF 0.10
- Stochastic Oscillator
- DERM 92.41
- PROF 87.93
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.